{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:18:46Z","timestamp":1789906726392,"version":"4.0.1"},"reference-count":20,"publisher":"BMJ","issue":"6800","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1991,8,24]]},"DOI":"10.1136\/bmj.303.6800.435","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T12:16:37Z","timestamp":1238415397000},"page":"435-437","source":"Crossref","is-referenced-by-count":276,"title":["Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee."],"prefix":"10.1136","volume":"303","author":[{"given":"C C","family":"McDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","reference":[{"issue":"1","key":"ref_1","first-page":"83","article-title":"Hamilton 'l', Langlands AO, McFadyen IJ, ei al. The tamoxifen trial -a double-blind comparisonl with stil'strol in postmenopausal women with advanced breast canccr","volume":"16","author":"Stewart, H.J.; Forrest, A.P.M.; Gunn, J.M.","year":"1980","unstructured":"Stewart HJ, Forrest APM, Gunn JM, Hamilton 'l', Langlands AO, McFadyen IJ, ei al. The tamoxifen trial -a double-blind comparisonl with stil'strol in postmenopausal women with advanced breast canccr. Eur7 Cancer 1980; 16:(suppl 1):83-8.","journal-title":"Eur7 Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJM198812293192601","article-title":"Early Breast Cancer Trialists' Collaborative Group. Eff'ccts of adjuvant tamoxifen and of cytotoxic therapy on mortality in carly breast canccr","volume":"319","year":"1988","unstructured":"Early Breast Cancer Trialists' Collaborative Group. Eff'ccts of adjuvant tamoxifen and of cytotoxic therapy on mortality in carly breast canccr. N Engl_Med 1988;319:1681-92.","journal-title":"N Engl_Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJM198902233200802","article-title":"A randomised clinical trial evaluatitig tamoxifen in the treatment of patients with node-negative breast cancer who have ocstrogen receptor positive tumours","volume":"320","author":"Fisher, B.; Constantino, J.; Redmond, C.; IPoisson, R.; Bowman, D.; Couture, J.","year":"1989","unstructured":"Fisher B, Constantino J, Redmond C, IPoisson R, Bowman D, Couture J, et al. A randomised clinical trial evaluatitig tamoxifen in the treatment of patients with node-negative breast cancer who have ocstrogen receptor positive tumours. N Engl 7.Mcfd 1989;320:479-84.","journal-title":"N Engl"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/0003-4819-106-5-649","article-title":"Prolonging tamoxifen therapy for primary breast cancer: Findings from the national stirgical adjuvant breast and bowel project clinical trial","volume":"106","author":"Fisher, B.; Brown, A.; Wolmark, N.; Redmond, C.; WXickerham, D.L.; Wittliff, J.","year":"1987","unstructured":"Fisher B, Brown A, Wolmark N, Redmond C, WXickerham DL, Wittliff J, et al. Prolonging tamoxifen therapy for primary breast cancer: Findings from the national stirgical adjuvant breast and bowel project clinical trial. Ann Intern Med 1987;106:649-54.","journal-title":"Ann Intern Med"},{"key":"ref_5","first-page":"584","article-title":"Effect ot estrogens and antiestrogens on growth of huLmain breast cancer cells in athymic nude mice","volume":"45","author":"Osborne, C.K.; Hobbs, K.; Clark, G.M.","year":"1985","unstructured":"Osborne CK, Hobbs K, Clark GM. Effect ot estrogens and antiestrogens on growth of huLmain breast cancer cells in athymic nude mice. Cancer Res 1985;45:584-90.","journal-title":"Cancer Res"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/07357908809082124","article-title":"Chemosuppression of breast cancer with tamoxifen: laboratory esidence and future clinical investigations","volume":"6","author":"Jordan, V.C.","year":"1988","unstructured":"Jordan VC. Chemosuppression of breast cancer with tamoxifen: laboratory esidence and future clinical investigations. Cancer Invest 1988;6:5-1 1.","journal-title":"Cancer Invest"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/bjc.1989.235","article-title":"A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer","volume":"60","author":"Powles, T.J.; Hardy, JR, Ashlev; SE, Farrington; GMNI, Cosgrose; D, Davev; J.B.","year":"1989","unstructured":"Powles TJ, Hardy JR, Ashlev SE, Farrington GMNI, Cosgrose D, Davev JB, et al. A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer. BrJ Cancer 1989;60:126-31.","journal-title":"BrJ Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bjc.1988.248","article-title":"serum lipoproteins and cardiovascular risk","volume":"58","author":"Bruning, P.F.; Bonfrer, J.M.; Hart, A.A.; Ml, De Jong-Bakker; Linders, D.; Van Loon, J.","year":"1988","unstructured":"Bruning PF, Bonfrer JM, Hart AA, De Jong-Bakker Ml, Linders D, Van Loon J, et al. Tamoxifen, serum lipoproteins and cardiovascular risk. BrJ Cancer 1988;58:497-9.","journal-title":"BrJ Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/endo-122-3-1146","article-title":"Tamoxifen inhibits osteoclast mediated resorption of trabecular bone in os-arian hormone deficient rats","volume":"122","year":"1988","unstructured":"Turner RT, Wakeley (UK, Hannon KS, Bell NH. Tamoxifen inhibits osteoclast mediated resorption of trabecular bone in os-arian hormone deficient rats. Endocrinologv 1988;122:1146-50.","journal-title":"Endocrinologv"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF01811242","article-title":"Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years","volume":"12","author":"Love, R.R.; Mazess, R.B.; Tormay, D.C.; Barden, H.S.; P'A, Newcomb; Jordan, V.C.","year":"1988","unstructured":"Love RR, Mazess RB, Tormay DC, Barden HS, Newcomb P'A, Jordan VC. Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years. Breast Cancer Res Treat 1988;12:297-301.","journal-title":"Breast Cancer Res Treat"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jnci\/81.14.1086","article-title":"Effects of tamoxifen on spinal bone density in womcn with breast cancer..7 Natl","volume":"81","author":"Turkin, S.; Siris, E.; Seldin, D.; Flaster, E.; Hvman, G.; Lindsay, R.","year":"1989","unstructured":"Turkin S, Siris E, Seldin D, Flaster E, Hvman G, Lindsay R. Effects of tamoxifen on spinal bone density in womcn with breast cancer..7 Natl Cancer Inst 1989;81:1086-8.","journal-title":"Cancer Inst"},{"key":"ref_12","first-page":"171","article-title":"Breast Cancer 'I'rials Committee. Adjuvant tamoxifeni in the management of operable breast cancer: the Scottish trial","volume":"ii:","year":"1987","unstructured":"Breast Cancer 'I'rials Committee. Adjuvant tamoxifeni in the management of operable breast cancer: the Scottish trial. Lant-et 1987;ii: 171-6.","journal-title":"Lant-et"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(84)90043-3","article-title":"The pharmacology and clinical uses of tamoxifen","volume":"25","author":"Furr, B.J.A.; X'C, Jordan","year":"1984","unstructured":"Furr BJA, Jordan X'C. The pharmacology and clinical uses of tamoxifen. Pharnacol Ther 1984;25:127-205.","journal-title":"Pharnacol Ther"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF01811244","article-title":"Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels","volume":"12","author":"true","year":"1988","unstructured":"Bertelli G, 1ronzato P, Amoroso D, Cusimano MP, Conte PF, Miontagna G, et al. Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels. Breast Cancer Res Treat 1988;12:307-10.","journal-title":"Breast Cancer Res Treat"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1677\/joe.0.1190335","article-title":"Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain","volume":"119","author":"Al, Caleffi; IS, Fentiman; GM, Clark; DY, Wang; J, Needham; K, Clark","year":"1988","unstructured":"Caleffi Al, Fentiman IS, Clark GM, Wang DY, Needham J, Clark K, et al. Effect of tamoxifen on oestrogen binding, lipid and lipoprotein concentrations and blood clotting parameters in premenopausal women with breast pain.J Endocrinol 1988;119:335-9.","journal-title":"J Endocrinol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/jnci\/82.16.1327","article-title":"Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer","volume":"82","author":"Lose, R.R.; Newcomb, P.A.; Wiebe, D.A.; I'S, Surawicz; Jordan, V.C.; Carbone, P.P.","year":"1990","unstructured":"Lose RR, Newcomb PA, Wiebe DA, Surawicz I'S, Jordan VC, Carbone PP, et al. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer..J Nail Cancer Inst 1990;82:1327-32.","journal-title":"J Nail Cancer Inst"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0002-9378(88)80074-7","article-title":"Estrogen replacement therapy and protection from actute myocardial infarction","volume":"159","author":"Henderson, B.E.; laganini-Hill, A.; Ross, R.K.","year":"1988","unstructured":"Henderson BE, laganini-Hill A, Ross RK. Estrogen replacement therapy and protection from actute myocardial infarction. Am 7 Obstet Gynecol 1988;159: 312-7.","journal-title":"Am 7 Obstet Gynecol"},{"key":"ref_18","first-page":"1470","article-title":"Oestrogens, arterial status, and postmenopausal women","volume":"i:","year":"1990","unstructured":"Bourne -r, Hillard Tc, Whitehead MI, Crook D, Campbell S. Oestrogens, arterial status, and postmenopausal women. Lancet 1990;i: 1470-1.","journal-title":"Lancet"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Reaven (iM. Role of insulin resistance in human disease","volume":"37","year":"1988","unstructured":"Reaven (iM. Role of insulin resistance in human disease. Diabetes 1988;37: 1595-607.","journal-title":"Diabetes"},{"key":"ref_20","first-page":"638","article-title":"Tamoxifen and arterial thrombosis","volume":"i:","author":"Dahan, R.; Espie, M.; Mignot, L.; Houlbert, D.; Chanu, B.","year":"1985","unstructured":"Dahan R, Espie M, Mignot L, Houlbert D, Chanu B. Tamoxifen and arterial thrombosis. Lancet 1985;i:638.","journal-title":"Lancet"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.303.6800.435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T10:38:03Z","timestamp":1601116683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.303.6800.435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,8,24]]},"references-count":20,"journal-issue":{"issue":"6800","published-print":{"date-parts":[[1991,8,24]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.303.6800.435","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,8,24]]}}}